La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
ELV Aperçu des actions
Elevance Health, Inc. et ses filiales opèrent en tant que société de prestations de santé aux États-Unis.
| Score flocon de neige | |
|---|---|
| Évaluation | 5/6 |
| Croissance future | 1/6 |
| Performances passées | 3/6 |
| Santé financière | 4/6 |
| Dividendes | 3/6 |
Récompenses
Analyse des risques
ELV ont passé avec succès nos contrôles de risques.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Strategic Initiatives And Analytical Optimism Signal Bright Future In Healthcare Sector
Elevance Health, Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$523.95 |
| Plus haut sur 52 semaines | US$567.26 |
| Plus bas sur 52 semaines | US$431.38 |
| Bêta | 0.83 |
| 1Variation sur 1 mois | -5.92% |
| Variation sur 3 mois | -1.98% |
| Variation sur 1 an | 20.33% |
| 3Variation sur 3 ans | 39.37% |
| Variation sur 5 ans | 116.70% |
| Évolution depuis l'introduction en bourse | 2,462.10% |
Nouvelles et mises à jour récentes
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11
Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Recent updates
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Rendement pour les actionnaires
| ELV | US Healthcare | US Marché | |
|---|---|---|---|
| 7D | -2.9% | 0.3% | 0.9% |
| 1Y | 20.3% | 12.0% | 32.3% |
Rendement vs Industrie: ELV a dépassé le secteur US Healthcare qui a rapporté 12.4 % au cours de l'année écoulée.
Rendement vs marché: ELV a sous-performé le marché US qui a rapporté 25.3 % au cours de l'année écoulée.
Volatilité des prix
| ELV volatility | |
|---|---|
| ELV Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: ELV n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de ELV ( 4% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc. et ses filiales opèrent en tant que société de prestations de santé aux États-Unis. La société opère à travers quatre segments : Health Benefits, CarelonRx, Carelon Services et Corporate & Other. Elle offre une variété de plans et de services de santé aux membres du programme, des produits de santé, une gamme de services administratifs de gestion des soins basés sur des honoraires, ainsi que des produits et services d'assurance spécialisés et autres, tels que l'assurance en excédent de pertes, l'assurance dentaire, l'assurance vision, l'assurance vie, l'assurance invalidité et les prestations d'assurance maladie complémentaire.
Elevance Health, Inc. Résumé des fondamentaux
| ELV statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$121.50b |
| Bénéfices(TTM) | US$6.69b |
| Recettes(TTM) | US$171.72b |
18.2x
Ratio P/E0.7x
Ratio P/SLe site ELV est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| ELV compte de résultat (TTM) | |
|---|---|
| Recettes | US$171.72b |
| Coût des recettes | US$123.06b |
| Marge brute | US$48.66b |
| Autres dépenses | US$41.97b |
| Les revenus | US$6.69b |
Derniers bénéfices déclarés
Jun 30, 2024
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 28.85 |
| Marge brute | 28.34% |
| Marge bénéficiaire nette | 3.90% |
| Ratio dettes/capitaux propres | 71.8% |
Quelles ont été les performances à long terme de ELV?
Voir les performances historiques et les comparaisons